Talphera (TLPH) Share-based Compensation (2010 - 2026)
Talphera (TLPH) posted quarterly Share-based Compensation of $214000.0 for Q1 2026, up 9.18% year-over-year from $196000.0 in Q1 2025, and up 147.56% quarter-over-quarter from -$450000.0 in Q4 2025.
Talphera (TLPH) Share-based Compensation (2010 - 2026) Analysis & Trends
Talphera's Share-based Compensation history runs 17 years deep, the most recent figure standing at $214000.0 for Q1 2026.
- In Q1 2026, Share-based Compensation rose 9.18% year-over-year to $214000.0; the TTM figure through Mar 2026 stood at $112000.0 (up 761.54% YoY), while the FY2025 annual figure was $1.0 million, up 740.34% from the prior year.
- Share-based Compensation for Q1 2026 stood at $214000.0, up from -$450000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $2.8 million in Q4 2022, with the low at -$640000.0 in Q4 2024.
- The 5-year median for Share-based Compensation is $302000.0 (2024), against an average of $433882.4.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation soared 881.03% in 2023, then slumped 305.79% in 2024.
- Talphera's Share-based Compensation stood at $2.8 million in 2022, then sank by 88.91% to $311000.0 in 2023, then plunged by 305.79% to -$640000.0 in 2024, then rose by 29.69% to -$450000.0 in 2025, then jumped by 147.56% to $214000.0 in 2026.
- Business Quant data shows TLPH's Share-based Compensation at $214000.0 in Q1 2026, -$450000.0 in Q4 2025, and $152000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 40.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 26.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 114.12 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 19.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 30.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 65.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 7.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Talphera | 90.63 Mn | 90.63 Mn | - | 1.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.70 Mn |
| Jun 30, 2026 | 1.70 Mn |
| Mar 31, 2026 | 214,000.00 |
| Mar 31, 2026 | 214,000.00 |
| Dec 31, 2025 | -450,000.00 |
| Dec 31, 2025 | -450,000.00 |
| Sep 30, 2025 | 152,000.00 |
| Sep 30, 2025 | 152,000.00 |
| Jun 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 196,000.00 |
| Mar 31, 2025 | 196,000.00 |
| Dec 31, 2024 | -640,000.00 |
| Dec 31, 2024 | -640,000.00 |
| Sep 30, 2024 | 234,000.00 |
| Sep 30, 2024 | 234,000.00 |
| Jun 30, 2024 | 223,000.00 |
| Jun 30, 2024 | 223,000.00 |
| Mar 31, 2024 | 302,000.00 |
| Mar 31, 2024 | 302,000.00 |